Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2

Autor: Perrier-Trudova, V., Huimin, B. W., Kongpetch, S., Huang, D., Ong, P., Le Formal, A., Poon, S. L., Siew, E. Y., Myint, S. S., Gad, S., Gardie, B., Couvé, S., Foong, Y. M., Choudhury, Y., Poh, J., Ong, C. K., Toh, C. K., Ooi, A., Richard, S., Tan, M. -H, Bin Tean Teh

Publikováno v: Scopus-Elsevier
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2015, 35 (12), pp.6639-53
Anticancer Research, 2015, 35 (12), pp.6639-53
ResearcherID

International audience; Background/Aim: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare autosomal dominant disorder characterized by fumarate hydratase (FH) gene mutation. It is associated with the development of very aggressive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cb7e2ee0fbf39e71c1f60a966784331f
http://www.scopus.com/inward/record.url?eid=2-s2.0-84982298240&partnerID=MN8TOARS